Drug Shortage Report for IPRAVENT
| Report ID | 85654 |
| Drug Identification Number | 02246084 |
| Brand name | IPRAVENT |
| Common or Proper name | Ipravent |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IPRATROPIUM BROMIDE |
| Strength(s) | 0.06% |
| Dosage form(s) | SOLUTION |
| Route of administration | NASAL |
| Packaging size | 15ML |
| ATC code | R01AX |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-06-05 |
| Estimated end date | 2019-07-19 |
| Actual end date | 2019-07-18 |
| Shortage status | Resolved |
| Updated date | 2019-08-22 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.